The case for prehabilitation is no longer built on theory, it is built on data. Over the past decade, a substantial and growing body of clinical research has established that structured pre-operative preparation reduces complications, shortens hospital stays and accelerates functional recovery. This post examines what the evidence actually shows, where it is strongest, and why the findings have significant implications for how surgical care is delivered at scale.
What the Research Base Looks Like
The prehabilitation evidence base has matured considerably since the early 2000s. What began as small, single-centre studies has grown into a field supported by systematic reviews, meta-analyses and randomised controlled trials across multiple surgical specialties. Research now spans colorectal, cardiac, orthopaedic, urological and oncology surgery, and findings are remarkably consistent across all of them.
Perhaps the most important shift in recent years has been the move from unimodal prehabilitation (programmes focused on a single intervention such as exercise alone) to multimodal prehabilitation, which combines physical conditioning, nutritional optimisation and psychological preparation. Evidence consistently shows that multimodal approaches produce significantly better outcomes than any single intervention delivered in isolation.
This matters for how we interpret the data. Studies that tested exercise-only programmes, often in controlled laboratory settings, tend to underestimate the full effect size available from a well-designed multimodal programme. Headline statistics now emerging from multimodal trials are considerably more striking, and considerably more relevant to real-world surgical populations.
The Complication Data
The most cited finding in prehabilitation research is the reduction in postoperative complications. According to a systematic review published in the British Journal of Anaesthesia, patients who completed a multimodal prehabilitation programme experienced 64% fewer postoperative complications compared to those receiving standard care. This is not a marginal improvement, it represents a fundamental shift in surgical risk for the patients involved.
To understand why this happens, it helps to consider what complications actually reflect. Most postoperative complications, including respiratory infections, wound breakdown, cardiovascular events and delirium, are not random. They are strongly predicted by a patient’s pre-operative physiological reserve: their cardiovascular fitness, nutritional status, muscle mass and psychological resilience. Prehabilitation directly improves each of these factors. The result is a patient who arrives at surgery biologically better prepared to withstand and recover from the surgical stress response.
It is also worth noting that complication reduction is not evenly distributed across patient groups. The evidence is strongest for patients with comorbidities, those with diabetes, obesity, cardiovascular disease or signs of frailty. These are precisely the patients who make up the largest share of elective surgical lists in the NHS and comparable health systems. The populations most likely to benefit are also, currently, the least likely to have access to prehabilitation, a gap we examine in more detail in our post on why 90% of surgical patients miss out on prehabilitation.
The Hospital Stay Evidence
Alongside complication rates, length of stay is the outcome most consistently reported across prehabilitation studies, and the findings are equally compelling. According to a meta-analysis published in JAMA Surgery, patients who completed prehabilitation before major abdominal surgery had hospital stays that were, on average, 3.7 days shorter than control patients. Across a health system managing tens of thousands of surgical admissions annually, that figure has significant operational and financial implications.
The mechanism here is well understood. Shorter stays are not simply a product of fewer complications, though that contributes. They also reflect faster return to functional capacity after surgery. Patients who arrive fit recover faster. Respiratory systems cope better with anaesthesia. Muscles respond more effectively to early mobilisation. Nutritional reserves support tissue repair. The cumulative effect is a recovery trajectory that is faster across every dimension, and that translates directly into earlier safe discharge.
ERAS (Enhanced Recovery After Surgery) protocols have driven significant improvements in postoperative care over the past two decades. The emerging evidence suggests that prehabilitation is the natural complement to ERAS, addressing the pre-operative period with the same rigour that ERAS brought to the postoperative phase. Together, they represent the most complete approach currently available to optimising surgical outcomes across the full perioperative care pathway.
What the Research Says About Specific Populations
The evidence for prehabilitation is not restricted to elite surgical candidates, it is most powerful precisely in the patients who have historically been considered too unwell to prepare.
Cancer surgery represents one of the most studied and most compelling areas of the prehabilitation evidence base. Patients undergoing surgery for colorectal, oesophageal, lung and urological cancers face a particular challenge: they are often nutritionally depleted, physically deconditioned and psychologically distressed at the point of diagnosis, exactly when the pre-operative window begins. A systematic review in Surgical Oncology found that prehabilitation in cancer surgical patients was associated with significant improvements in exercise capacity, reduced complication rates and faster return to baseline function. We examine this evidence in depth in our post on prehabilitation for cancer surgery.
The evidence for orthopaedic populations, particularly patients undergoing total hip and knee replacement, is similarly robust. A Cochrane review found that pre-operative exercise programmes produced meaningful improvements in short-term functional outcomes and reduced length of stay. Importantly, the benefits were observed even in patients with significant frailty or sarcopaenia, the loss of muscle mass that dramatically worsens surgical outcomes. Even modest gains in pre-operative strength translate into meaningfully faster postoperative recovery.
Cardiac surgery patients represent a third population where the evidence is accumulating quickly. A 2024 RCT published in BMC Cardiovascular Disorders found that patients who completed a structured prehabilitation programme before elective cardiac surgery had a complication rate of 12% compared to 28% in the control group, a reduction that was both clinically and statistically significant. Length of stay was also reduced, from 8.2 days to 6.4 days. These are not marginal differences. They represent outcomes that would be considered transformative in any other area of surgical care.
The Gap Between Evidence and Practice
Despite this evidence, prehabilitation remains unavailable to the vast majority of surgical patients. Delivery has historically depended on specialist physiotherapy teams, hospital-based programmes and face-to-face contact, resources that are scarce, geographically uneven and difficult to scale. A patient in a major teaching hospital may have access to a supervised prehabilitation programme. A patient in a rural community almost certainly does not. The evidence supports the intervention. The infrastructure does not yet support its delivery at scale. That is the gap that digital health platforms are now beginning to address, and the gap that Clovo was specifically built to close. For a broader look at what prehabilitation actually involves, our complete guide to prehabilitation covers the full picture.
The economic case is also increasingly difficult to ignore. Value-based care frameworks, which tie reimbursement to outcomes rather than activity, create direct institutional incentives to invest in pre-operative preparation. When a 3.7-day reduction in average length of stay is achievable for a fraction of the cost of managing complications, the return on investment for prehabilitation becomes straightforward to calculate. The evidence does not just support the clinical case. It supports the commissioning case.
How Clovo Can Help
At Clovo, everything we build is grounded in the clinical evidence outlined in this post. Our platform exists because the research is clear, and because the infrastructure to deliver that research at scale has not previously existed. Amy, our AI recovery coach, delivers multimodal prehabilitation programmes personalised to each patient’s baseline, procedure type, risk profile and goals. She monitors progress, adapts programming in real time and ensures that the interventions with the strongest evidence base are the ones every patient receives, regardless of where they live or which hospital they attend.
Our CMO, Dr Rebecca Hughes MRCS, leads Clovo’s clinical governance framework to ensure that everything Amy delivers is grounded in current best evidence. Our approach to outcomes measurement means that every patient on the platform contributes to a growing dataset, one that will allow us to continue refining and improving what we deliver. To understand how Clovo tracks and reports on patient outcomes, see how Clovo measures patient outcomes. To learn more about how Clovo’s clinical safety framework is structured, visit Clovo’s clinical safety framework.
The evidence for prehabilitation is not emerging, it has arrived. What remains is the challenge of translating that evidence into consistent, scalable delivery for every patient who needs it. That is the work Clovo is doing, and it is the reason the research in this post matters beyond the academic literature it currently lives in.
| Related Reading |
| What is Prehabilitation? A Complete Guide for Surgical Patients The definitive explainer on what prehabilitation is, how it works and who it’s for, the essential starting point before diving into the evidence. |
| Why 90% of Surgical Patients Miss Out on Prehabilitation The evidence is clear, so why aren’t more patients receiving prehabilitation? This post examines the access gap and what it costs patients and health systems. |
| How Clovo Measures Patient Outcomes How Clovo captures, tracks and reports on the clinical outcomes that matter most, and how that data feeds back into improving what every patient receives. |
